2-(4-(Benzo[c][1,2,5]thiadiazol-5-yl)-3-(6-methylpyridin-2-yl)-1H-pyrazol-1-yl)-N-(3-cyanophenyl)acetamide

ID: ALA4474331

PubChem CID: 155536957

Max Phase: Preclinical

Molecular Formula: C24H17N7OS

Molecular Weight: 451.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1

Standard InChI:  InChI=1S/C24H17N7OS/c1-15-4-2-7-21(26-15)24-19(17-8-9-20-22(11-17)30-33-29-20)13-31(28-24)14-23(32)27-18-6-3-5-16(10-18)12-25/h2-11,13H,14H2,1H3,(H,27,32)

Standard InChI Key:  UUNISKASUMHIFH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   38.9360   -3.8781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6457   -3.4687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6428   -2.6460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9342   -2.2408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2254   -3.4709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2321   -2.6496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4530   -2.3895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.9648   -3.0500    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   37.4423   -3.7183    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.3545   -3.8738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4412   -4.6863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2409   -4.8550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.6484   -4.1466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.1005   -3.5403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8366   -5.2313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0587   -4.9779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4537   -5.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6208   -6.3221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3987   -6.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0095   -6.0287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.5671   -7.3752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4651   -4.1437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8761   -4.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6933   -4.8472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.4700   -5.5591    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.1044   -5.5534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6958   -6.2597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1062   -6.9655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9242   -6.9631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.3302   -6.2490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9174   -5.5461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1464   -6.2401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.9636   -6.2343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9  5  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 10  2  0
  2 10  1  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 11 15  1  0
 19 21  1  0
 13 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 32 33  3  0
 30 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4474331

    ---

Associated Targets(Human)

TGFBR1 Tchem TGF-beta receptor type I (3786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.52Molecular Weight (Monoisotopic): 451.1215AlogP: 4.44#Rotatable Bonds: 5
Polar Surface Area: 109.38Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.96CX Basic pKa: 1.81CX LogP: 4.29CX LogD: 4.29
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.42Np Likeness Score: -2.19

References

1. Zhu WJ, Cui BW, Wang HM, Nan JX, Piao HR, Lian LH, Jin CH..  (2019)  Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives.,  180  [PMID:31299584] [10.1016/j.ejmech.2019.07.013]

Source